Log in

Relevant bibliographies by topics / Hydrocodone Rescheduling

Contents

Journal articles

Academic literature on the topic 'Hydrocodone Rescheduling'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hydrocodone Rescheduling.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hydrocodone Rescheduling"

1

Neuman, Mark D., Sean Hennessy, Dylan S. Small, et al. "Drug Enforcement Agency 2014 Hydrocodone Rescheduling Rule and Opioid Dispensing after Surgery." Anesthesiology 132, no. 5 (2020): 1151–64. http://dx.doi.org/10.1097/aln.0000000000003188.

Full text

Abstract:

Abstract Background In 2014, the U.S. Drug Enforcement Agency reclassified hydrocodone from Schedule III to Schedule II of the Controlled Substances Act, resulting in new restrictions on refills. The authors hypothesized that hydrocodone rescheduling led to decreases in total opioid dispensing within 30 days of surgery and reduced new long-term opioid dispensing among surgical patients. Methods The authors studied privately insured, opioid-naïve adults undergoing 10 general or orthopedic surgeries between 2011 and 2015. The authors conducted a differences-in-differences analysis that compared

APA, Harvard, Vancouver, ISO, and other styles

2

Fernandez, PharmD, BCPS, CGP, Julianna, James Douglas Thornton, PhD, PharmD, BCPS, Sanika Rege, MS, et al. "Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study." Journal of Opioid Management 14, no. 5 (2018): 317–26. http://dx.doi.org/10.5055/jom.2018.0464.

Full text

Abstract:

Objective: To qualitatively assess prescribers’ perceptions regarding the consequences associated with hydrocodone rescheduling among geriatric patients being discharged from inpatient settings.Design: This was a cross-sectional study.Setting: Two focus groups were conducted by a trained facilitator in a metropolitan academic medical center in January 2016.Participants: Prescribers who manage noncancer pain for geriatric patients were recruited. Focus groups were recorded, transcribed, and then analyzed using ATLAS.ti Qualitative Data Analysis software. Codes were derived from six primary rese

APA, Harvard, Vancouver, ISO, and other styles

3

Liu, Yingna, Olesya Baker, Jeremiah D. Schuur, and Scott G. Weiner. "Effects of Rescheduling Hydrocodone on Opioid Prescribing in Ohio." Pain Medicine 21, no. 9 (2019): 1863–70. http://dx.doi.org/10.1093/pm/pnz210.

Full text

Abstract:

Abstract Background We quantified opioid prescribing after the 2014 rescheduling of hydrocodone from schedule III to II in the United States using a state-wide prescription database and studied trends three years before and after the policy change, focusing on certain specialties. Methods We used Ohio’s state prescription drug monitoring program database, which includes all filled schedule II and III prescriptions regardless of payer or pharmacy, to conduct an interrupted time series analysis of the nine most prescribed opioids: hydrocodone, oxycodone, tramadol, codeine, and others. We analyze

APA, Harvard, Vancouver, ISO, and other styles

4

Lipman, Arthur. "AMA Fact Sheet on Hydrocodone Rescheduling." Journal of Pain & Palliative Care Pharmacotherapy 29, no. 1 (2015): 82–97. http://dx.doi.org/10.3109/15360288.2014.1003684.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Yap, Diana. "FDA advisory committee recommends hydrocodone rescheduling." Pharmacy Today 19, no. 3 (2013): 71. http://dx.doi.org/10.1016/s1042-0991(15)31504-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "The rescheduling of hydrocodone combination products." Reactions Weekly &NA;, no. 1426 (2012): 5. http://dx.doi.org/10.2165/00128415-201214260-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Traynor, Kate. "FDA advisers support rescheduling of hydrocodone products." American Journal of Health-System Pharmacy 70, no. 5 (2013): 382–84. http://dx.doi.org/10.2146/news130017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Shumway, MD, John W., Renzhong Ran, MD, Jeff McClusky, BS, Pharm, et al. "Impact of rescheduling hydrocodone-combination products in an urban Texas county healthcare system." Journal of Opioid Management 14, no. 4 (2018): 257–64. http://dx.doi.org/10.5055/jom.2018.0457.

Full text

Abstract:

Objective: The objective of this study was to examine the rescheduling of hydrocodone- combination products (HCPs) and associated changes in prescriber patterns in an urban county healthcare system in Texas.Methods: Pharmacy data were obtained electronically for tramadol, hydrocodone-acetaminophen, and acetaminophen-codeine from 180 days before and after the schedule change on October 6, 2014. χ2 and t tests were used to calculate the significance of changes between the medications over the studied time.Results: Hydrocodone-acetaminophen saw a decline in dispense events and pills dispensed of

APA, Harvard, Vancouver, ISO, and other styles

9

Liaw, Victor, Yong-Fang Kuo, Mukaila A. Raji, and Jacques Baillargeon. "Opioid Prescribing Among Adults With Disabilities in the United States After the 2014 Federal Hydrocodone Rescheduling Regulation." Public Health Reports 135, no. 1 (2019): 114–23. http://dx.doi.org/10.1177/0033354919892638.

Full text

Abstract:

Objectives: Deaths from prescription opioid overdoses have reached an epidemic level in the United States, particularly among persons with disabilities. The 2014 federal rescheduling regulation is associated with reduced opioid prescribing in the general US population; however, to date, no data have been published on this regulation’s effect on persons with disabilities. We examined whether the 2014 hydrocodone rescheduling change was associated with reduced opioid prescribing among adult Medicare beneficiaries with disabilities. Methods: We identified 680 876 Medicare beneficiaries with disab

APA, Harvard, Vancouver, ISO, and other styles

10

Schultz, PharmD, Steven, Carol Chamberlain, PharmD, Psych MA, Marius Vulcan, MD, Humair Rana, MD, Bhavin Patel, PharmD, MBA, and John C. Alexander, MD. "Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center." Journal of Opioid Management 12, no. 2 (2016): 119. http://dx.doi.org/10.5055/jom.2016.0323.

Full text

Abstract:

Background: Hydrocodone-containing products were recently rescheduled from Drug Enforcement Agency (DEA) schedule III to schedule II due to concerns of abuse and misuse. These changes went into effect on October 6, 2014. Objective: This quality improvement project involved a retrospective analysis to determine the effect of the DEA schedule change on prescribing habits of hydrocodone-containing products as well as the remaining schedule III and IV opioids, codeine (schedule III) and tramadol (schedule IV).Methods: The authors performed a medication use evaluation at our academic level 1 trauma

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!